VitsGen: Targeted Radiotherapy

English 简体中文

18 2025-03

VitsGen CEO & CSO Invited Speakers at TRP US
26 2024-08

Meeting VitsGen Therapeutics, Inc. at SNMMI 2024 Therapeutics Conference, Booth #13
11 2024-07

In 2030 the overall 5-year survival rate for cancer would reach 46.6%

Total 3 record(s)1

Copyright ©2004-2024 All Rights Reserved. All copies are strictly prohibited without permission